Nitric oxide and traumatic brain injury

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Traumatic brain injury (TBI) involves significant dysregulation of the nitric oxide/nitric oxide synthase (NO/NOS) system.
• The NO/NOS system exhibits a paradoxical role in TBI progression, influencing both injury and recovery.
• Altered NO/NOS homeostasis is a consistent finding post-TBI, necessitating targeted therapeutic interventions.

Purpose of the Study:

• To review the dynamic contributions of nitric oxide to TBI pathophysiology.
• To highlight emerging therapeutic interventions targeting NO-related pathways in TBI.
• To integrate findings from preclinical studies and clinical trials on NO modulation in TBI.

Main Methods:

• Literature review of preclinical studies and clinical trials.
• Analysis of the dual role of physiological and excessive nitric oxide production in TBI.
• Evaluation of therapeutic strategies targeting the NO/NOS system.

Main Results:

• Physiological NO levels are crucial for cerebral blood flow and neuroprotection.
• Excessive NO production, particularly via inducible nitric oxide synthase (iNOS), drives secondary injury, cytotoxicity, edema, and blood-brain barrier disruption.
• Therapeutic strategies including inhaled NO, NO donors, and NOS inhibitors (e.g., VAS203) show neuroprotective potential in preclinical TBI models.

Conclusions:

• The NO/NOS system is a critical modulator of TBI outcomes.
• Targeting NO pathways offers promising neuroprotective strategies for TBI.
• Clinical translation of NO-targeting therapies for TBI requires further investigation despite promising preclinical results.